Post-earnings recap
Reported
Fri, Nov 1, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's positive earnings surprise on EPS indicates stronger-than-expected profitability, which likely contributed to the 7.23% increase in stock price. Investors may view this as a sign of resilience and potential growth, especially given the management's focus on innovation. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.87 | N/A | +13.55% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's direction despite not providing specific guidance. They emphasized the importance of product development and market expansion.
Management highlighted strong performance in key product lines.
They noted ongoing investments in innovation to drive future growth.